Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Capital Employed (2021 - 2023)

Cullinan Therapeutics (CGEM) has 3 years of Return on Capital Employed data on record, last reported at 0.36% in Q3 2023.

  • For Q3 2023, Return on Capital Employed fell 60.0% year-over-year to 0.36%; the TTM value through Sep 2023 reached 0.36%, down 60.0%, while the annual FY2022 figure was 0.3%, 52.0% up from the prior year.
  • Return on Capital Employed reached 0.36% in Q3 2023 per CGEM's latest filing, down from 0.31% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.31% in Q2 2022 and bottomed at 0.36% in Q3 2023.
  • Average Return on Capital Employed over 3 years is 0.04%, with a median of 0.14% recorded in 2021.
  • The widest YoY moves for Return on Capital Employed: up 48bps in 2023, down -63bps in 2023.
  • A 3-year view of Return on Capital Employed shows it stood at 0.16% in 2021, then surged by 270bps to 0.27% in 2022, then crashed by -235bps to 0.36% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.36% in Q3 2023, 0.31% in Q2 2023, and 0.24% in Q1 2023.